Coleman E et al (2022) Standards of Care for the Health of Transgender and Gender Diverse People, Version 8, Int. J. Transgender Heal., vol. 23, no. sup1, pp. S1–S259. https://doi.org/10.1080/26895269.2022.2100644

Hembree WC et al (2017) Endocrine treatment of gender-dysphoric/ gender-incongruent persons: an endocrine society∗clinical practice guideline. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2017-01658

Article  PubMed  Google Scholar 

Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschueren D (2010) Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading., J. Endocrinol., vol. 207, no. 2, pp. 127–134, Nov. https://doi.org/10.1677/JOE-10-0209

Vanderschueren D et al (2014) Dec., Sex steroid actions in male bone., Endocr. Rev., vol. 35, no. 6, pp. 906–960. https://doi.org/10.1210/er.2014-1024

Alswat KA (2017) Gender disparities in osteoporosis. J Clin Med Res. https://doi.org/10.14740/jocmr2970w

Article  PubMed  PubMed Central  Google Scholar 

Van Caenegem E et al (2013) Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone. https://doi.org/10.1016/j.bone.2013.01.039

Article  PubMed  Google Scholar 

Fighera TM, da Silva E, Lindenau JDR, Spritzer PM (2018) Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen, Clin. Endocrinol. (Oxf)., vol. 88, no. 6, pp. 856–862, Jun. https://doi.org/10.1111/CEN.13607

Wierckx K et al (2012) Oct., Long-term evaluation of cross-sex hormone treatment in transsexual persons., J. Sex. Med., vol. 9, no. 10, pp. 2641–2651. https://doi.org/10.1111/j.1743-6109.2012.02876.x

Van Caenegem E et al (Jan. 2015) Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study. Osteoporos Int 26(1):35–47. https://doi.org/10.1007/S00198-014-2805-3

Wiepjes CM et al (2019) Mar., Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen, J. Bone Miner. Res., vol. 34, no. 3, pp. 447–454. https://doi.org/10.1002/JBMR.3612

Ceolin C et al (Jul. 2023) Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02156-7

Van Caenegem E et al (2012) Jul., Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy, J. Clin. Endocrinol. Metab., vol. 97, no. 7, pp. 2503–2511. https://doi.org/10.1210/jc.2012-1187

Van Caenegem E et al (2015) Feb., Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI), Eur. J. Endocrinol., vol. 172, no. 2, pp. 163–171. https://doi.org/10.1530/EJE-14-0586

Andrzejewski J, Calzo JP, Smith LR, Corliss HL, Felner JK (2023) Binge drinking disparities by gender identity, race, and ethnicity in California secondary schools. J LGBT Youth 20(4):896–917. https://doi.org/10.1080/19361653.2022.2113198

Article  PubMed  Google Scholar 

Deutsch MB, Bhakri V, Kubicek K (2015) Effects of cross-sex hormone treatment on transgender women and men., Obstet. Gynecol., vol. 125, no. 3, pp. 605–610, Mar. https://doi.org/10.1097/AOG.0000000000000692

Pan B et al (Mar. 2016) Genetic association between androgen receptor gene CAG repeat length polymorphism and male infertility: a Meta-analysis. Med (Baltim) 95(10):e2878. https://doi.org/10.1097/MD.0000000000002878

Ponce-González JG et al (2016) Nov., Androgen receptor gene polymorphism influence fat accumulation: A longitudinal study from adolescence to adult age., Scand. J. Med. Sci. Sports, vol. 26, no. 11, pp. 1313–1320. https://doi.org/10.1111/sms.12587

Shukla GC, Plaga AR, Shankar E, Gupta S (May 2016) Androgen receptor-related diseases: what do we know? Andrology 4(3):366–381. https://doi.org/10.1111/andr.12167

Guilherme JPLF et al (2021) Mar., Androgen receptor gene microsatellite polymorphism is associated with muscle mass and strength in bodybuilders and power athlete status., Ann. Hum. Biol., vol. 48, no. 2, pp. 142–149. https://doi.org/10.1080/03014460.2021.1919204

Sheppard RL, Spangenburg EE, Chin ER, Roth SM (2011) Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development., Physiol. Genomics, vol. 43, no. 20, pp. 1135–1143, Oct. https://doi.org/10.1152/physiolgenomics.00049.2011

Chen J-F, Lin P-W, Tsai Y-R, Yang Y-C, Kang H-Y (Oct. 2019) Androgens and androgen receptor actions on Bone Health and Disease: from Androgen Deficiency to Androgen Therapy. Cells 8(11). https://doi.org/10.3390/cells8111318

Almeida M et al (Jan. 2017) Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev 97(1):135–187. https://doi.org/10.1152/PHYSREV.00033.2015

Chang C, Yeh S, Lee SO, Chang T-M (2013) Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells. Nucl Recept Signal 11:e001. https://doi.org/10.1621/nrs.11001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corona G et al (May 2022) Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest 45(5):911–926. https://doi.org/10.1007/s40618-021-01702-5

MacLean HE et al (2010) Jul., DNA-binding-dependent androgen receptor signaling contributes to gender differences and has physiological actions in males and females., J. Endocrinol., vol. 206, no. 1, pp. 93–103. https://doi.org/10.1677/JOE-10-0026

Bouillon R, Bex M, Vanderschueren D, Boonen S (2004) Estrogens are essential for male pubertal periosteal bone expansion., J. Clin. Endocrinol. Metab., vol. 89, no. 12, pp. 6025–6029, Dec. https://doi.org/10.1210/jc.2004-0602

Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF (2003) A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures., Calcif. Tissue Int., vol. 73, no. 3, pp. 237–243, Sep. https://doi.org/10.1007/s00223-002-0019-8

Hirtz R et al (2021) Size matters: the CAG repeat length of the androgen receptor gene, testosterone, and male adolescent depression severity. Front Psychiatry 12:732759. https://doi.org/10.3389/fpsyt.2021.732759

Article  PubMed  PubMed Central  Google Scholar 

Chen H-Y, Chen W-C, Wu M-C, Tsai F-J, Tsai C-H (2003) Androgen receptor (AR) gene microsatellite polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis., Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 107, no. 1, pp. 52–56, Mar. https://doi.org/10.1016/s0301-2115(02)00315-9

Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, Nieschlag E (2001) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males., Clin. Endocrinol. (Oxf)., vol. 55, no. 5, pp. 649–657, Nov. https://doi.org/10.1046/j.1365-2265.2001.01391.x

Guadalupe-Grau A et al (Jul. 2010) Bone mass and the CAG and GGN androgen receptor polymorphisms in young men. PLoS ONE 5(7):e11529. https://doi.org/10.1371/journal.pone.0011529

Van Pottelbergh I, Lumbroso S, Goemaere S, Sultan C, Kaufman JM (2001) Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men., Clin. Endocrinol. (Oxf)., vol. 55, no. 5, pp. 659–666, Nov. https://doi.org/10.1046/j.1365-2265.2001.01403.x

Välimäki V-V, Piippo K, Välimäki S, Löyttyniemi E, Kontula K, Välimäki MJ (2005) The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men., Osteoporos. Int. a J. Establ. as result Coop. between Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA, vol. 16, no. 12, pp. 1633–1640, Dec. https://doi.org/10.1007/s00198-005-1889-1

Kenny AM, McGee D, Joseph C, Covault J, Abreu C, Raisz LG (2005) Lack of association between androgen receptor polymorphisms and bone mineral density or physical function in older men. Endocr Res 31(4):285–293. https://doi.org/10.1080/07435800500406221

Article  CAS  PubMed  Google Scholar 

Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum., J. Clin. Endocrinol. Metab., vol. 84, no. 10, pp. 3666–3672, Oct. https://doi.org/10.1210/jcem.84.10.6079

Keevil BG, Adaway J (Jun. 2019) Assessment of free testosterone concentration. J Steroid Biochem Mol Biol 190:207–211. https://doi.org/10.1016/j.jsbmb.2019.04.008

Garolla A et al (2005) Sep., Molecular analysis of the androgen receptor gene in testicular cancer., Endocr. Relat. Cancer, vol. 12, no. 3, pp. 645–655. https://doi.org/10.1677/erc.1.00954

Ferlin A et al (2006) Nov., Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations., Clin. Endocrinol. (Oxf)., vol. 65, no. 5, pp. 606–610. https://doi.org/10.1111/j.1365-2265.2006.02635.x

Zuccarello D et al (2008) Apr., Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility., Clin. Endocrinol. (Oxf)., vol. 68, no. 4, pp. 580–588. https://doi.org/10.1111/j.1365-2265.2007.03069.x

Richards S et al (May 2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med off J Am Coll Med Genet 17(5):405–424. https://doi.org/10.1038/gim.2015.30

Rothman MS, Iwamoto SJ (Jun. 2019) Bone Health in the Transgender Population. Clin Rev Bone Min Metab 17(2):77–85. https://doi.org/10.1007/s12018-019-09261-3

Ding D, Xu L, Menon M, Reddy GPV, Barrack ER (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action., Prostate, vol. 62, no. 2, pp. 133–139, Feb. https://doi.org/10.1002/pros.20128

D’Andrea S et al (2020) Mar., Polymorphic Cytosine-Adenine-Guanine Repeat Length of Androgen Receptor Gene and Gender Incongruence in Trans Women: A Systematic Review and Meta-Analysis of Case-Control Studies., J. Sex. Med., vol. 17, no. 3, pp. 543–550. https://doi.org/10.1016/j.jsxm.2019.12.010

Rocca MS et al (2023) Apr., Mutational Screening of Androgen Receptor Gene in 8224 Men of Infertile Couples., J. Clin. Endocrinol. Metab., vol. 108, no. 5, pp. 1181–1191. https://doi.org/10.1210/clinem/dgac671

Crabbe P, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM (2007) Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism., J. Clin. Endocrinol. Metab., vol. 92, no. 9, pp. 3604–3610, Sep. https://doi.org/10.1210/jc.2007-0117

Robeva R et al (2013) Aug., Androgen receptor (CAG)n polymorphism and androgen levels in women with systemic lupus erythematosus and healthy controls., Rheumatol. Int., vol. 33, no. 8, pp. 2031–2038. https://doi.org/10.1007/s00296-013-2687-2

Mouritsen A et al (2013) Mar., Androgen receptor CAG repeat length is associated with body fat and serum SHBG in boys: a prospective cohort study., J. Clin. Endocrinol. Metab., vol. 98, no. 3, pp. E605-9. https://doi.org/10.1210/jc.2012-3778

Bosman A et al (May 2023) Sexual dimorphisms in serum calcium and phosphate concentrations in the Rotterdam Study. Sci Rep 13(1):8310. https://doi.org/10.1038/s41598-023-34800-w

Jacquillet G, Unwin RJ (Jan. 2019) Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (pi). Pflugers Arch 471(1):83–98. https://doi.org/10.1007/s00424-018-2231-z